An advanced 3D lymphatic system for assaying human cutaneous lymphangiogenesis in a microfluidic platform
Source abstract
Abstract
Abstract The human cutaneous lymphatic system strictly controls lymphatic functions by coordinating with skin cells. The lymphatic system plays important roles in removing cell waste, residual proteins, various antigens, and immune cells from tissues to maintain homeostasis and activate the immune system through the drainage of interstitial fluid1,2. The skin protects our body from external stimuli such as pathogens through the cutaneous lymphatic system3,4. Herein, to develop an in vitro human cutaneous lymphatic model, we present two 3D microfluidic platforms: a lymphangiogenesis model with a precollecting lymphatic vessel-like structure and an advanced lymphangiogenesis model with a functional cutaneous barrier and a precollecting lymphatic vessel-like structure. In addition, we rapidly analyzed prolymphangiogenic effects using methods that incorporate a high-speed image processing system and a deep learning-based vascular network analysis algorithm by 12 indices. Using these platforms, we evaluated the pro-lymphangiogenic effect of Lymphanax, a natural product derived from fresh ginseng. As a result, we demonstrated that Lymphanax induces robust lymphangiogenesis without any structural abnormalities. In conclusion, we suggest that these innovative platforms are useful for studying the interaction between the skin and lymphatic system as well as evaluating the prolymphangiogenic effects of drugs and cosmetics.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Lymphatic System and Diseases · Sympathectomy and Hyperhidrosis Treatments · Body Contouring and Surgery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Margaris, K. N. & Black, R. A. Modelling the lymphatic system: Challenges and opportunities. J. R. Soc. Interface 9, 601–612 (2012).10.1098/rsif.2011.0751 ↗
2. Null, M. & Agarwal, M. Anatomy, Lymphatic System. (StatPearls Publishing: Treasure Island (FL), 2018. http://europepmc.org/abstract/MED/30020619 at.
3. Lund, A. W., Medler, T. R., Leachman, S. A. & Coussens, L. M. Lymphatic vessels, inflammation, and immunity in skin cancer. Cancer Discov. 6, 22–35 (2016).10.1158/2159-8290.CD-15-0023 ↗
4. Eyerich, S., Eyerich, K., Traidl-Hoffmann, C. & Biedermann, T. Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network. Trends Immunol. 39, 315–327 (2018).10.1016/j.it.2018.02.004 ↗
5. Stacker, S. A., et al. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat. Rev. Cancer 14, 159–172 (2014).10.1038/nrc3677 ↗
6. Jeltsch, M. et al. Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice. https://doi.org/10.1126/science.276.5317.1423 (1997).10.1126/science.276.5317.1423 ↗
7. Deng, Y., Zhang, X. & Simons, M. Molecular controls of lymphatic VEGFR3 signaling. Arterioscler Thromb. Vasc. Biol. 35, 421–429 (2015).10.1161/ATVBAHA.114.304881 ↗
8. Henderson, A. R., Choi, H. & Lee, E. Blood and lymphatic vasculatures on-chip platforms and their applications for organ-specific in vitro modeling. Micromachines 11, 147 (2020).10.3390/mi11020147 ↗
9. Olszewski, W. L. The Lymphatic System in Body Homeostasis: Physiological Conditions. Lymphat. Res. Biol. 1, 11–24 (2003).10.1089/15396850360495655 ↗
10. Alitalo, K., Tammela, T. & Petrova, T. V. Lymphangiogenesis in development and human disease. Nature 438, 946–953 (2005).10.1038/nature04480 ↗
11. Christiansen, A. & Detmar, M. Lymphangiogenesis and Cancer. Genes Cancer 2, 1146–1158 (2011).10.1177/1947601911423028 ↗
12. Kolarsick, P. A. J., Kolarsick, M. A. & Goodwin, C. Anatomy and Physiology of the Skin. J. Dermatol. Nurses Assoc. 3, 203–213 (2011).10.1097/JDN.0b013e3182274a98 ↗
13. Petrova, T. V. & Koh, G. Y. Organ-specific lymphatic vasculature: From development to pathophysiology. Journal of Experimental Medicine 215, 35–49 (2018).10.1084/jem.20171868 ↗
14. Stanley, G. & Rockson, M. D. Lymphedema. Am. J. Med. 110, 288–298 (2001).10.1016/S0002-9343(00)00727-0 ↗
15. Bruyère, F. & Noël, A. Lymphangiogenesis: in vitro and in vivo models. FASEB J. 24, 8–21 (2010).10.1096/fj.09-132852 ↗
16. Bruyère, F. et al. Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5, 431–437 (2008).10.1038/nmeth.1205 ↗
17. Halldorsson, S., Lucumi, E., Gómez-Sjöberg, R. & Fleming, R. M. T. Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. Biosens. Bioelectron. 63, 218–231 (2015).10.1016/j.bios.2014.07.029 ↗
18. Cui, P. & Wang, S. Application of microfluidic chip technology in pharmaceutical analysis: A review. J. Pharm. Anal. 9, 238–247 (2019).10.1016/j.jpha.2018.12.001 ↗
19. Kim, S., Chung, M. & Jeon, N. L. Three-dimensional biomimetic model to reconstitute sprouting lymphangiogenesis in vitro. Biomaterials 78, 115–128 (2016).10.1016/j.biomaterials.2015.11.019 ↗
20. Cho, Y. et al. Three-Dimensional In Vitro Lymphangiogenesis Model in Tumor Microenvironment. Front. Bioeng. Biotechnol. 9, 697657 (2021).10.3389/fbioe.2021.697657 ↗
21. Li, J. et al. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells. J. Ethnopharmacol. 193, 293–302 (2016).10.1016/j.jep.2016.08.032 ↗
22. Yu, J., Mao, L., Guan, L., Zhang, Y. & Zhao, J. Ginsenoside Rg1 enhances lymphatic transport of intrapulmonary silica via VEGF-C/VEGFR-3 signaling in silicotic rats. Biochem Biophys. Res Commun. 472, 182–188 (2016).10.1016/j.bbrc.2016.02.091 ↗
23. Miranda, I. et al. Properties and applications of PDMS for biomedical engineering: A review. J. Funct. Biomater. 13, 2 (2022).10.3390/jfb13010002 ↗
24. Shumbula, N. P. et al. Evaluating the antimicrobial activity and cytotoxicity of polydopamine capped silver and silver/polydopamine core-shell nanocomposites. Arab. J. Chem. 15, 103798 (2022).10.1016/j.arabjc.2022.103798 ↗
25. Jain, R. K. Molecular regulation of vessel maturation. Nat. Med. 9, 685–693 (2003).10.1038/nm0603-685 ↗
26. Herbert, S. P. & Stainier, D. Y. R. Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat. Rev. Mol. Cell Biol. 12, 551–564 (2011).10.1038/nrm3176 ↗
27. Choi, D.-H. et al. Analyzing angiogenesis on a chip using deep learning-based image processing. Lab Chip. https://doi.org/10.1039/D2LC00983H (2023).10.1039/D2LC00983H ↗
28. moonchildz. angio_analysis. (2023). at https://github.com/moonchildz/angio_analysis.
29. Shin, Y. et al. In vitro 3D collective sprouting angiogenesis under orchestrated ANG-1 and VEGF gradients. Lab Chip 11, 2175–2181 (2011).10.1039/c1lc20039a ↗
30. Jackson, D. G., Prevo, R., Clasper, S. & Banerji, S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol. 22, 317–321 (2001).10.1016/S1471-4906(01)01936-6 ↗
31. Wilting, J. et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J.: Off. Publ. Federation Am. Societies Exp. Biol. 16, 1271–1273 (2002).10.1096/fj.01-1010fje ↗
32. Kaipatnen, A. et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Med. Sci. 92, 3566–3570 (1995).
33. van Mourik, J. A., Leeksma, O. C., Reinders, J. H., de Groot, P. G. & Zandbergen-Spaargaren, J. Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane glycoprotein IIa. J. Biol. Chem. 260, 11300–11306 (1985).10.1016/S0021-9258(17)39180-9 ↗
34. Ji, R.-C., Kato, S., Shimoda, H. & Miura, M. Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix. Res. Biol. 4, 83–100 (2006).
35. Yao, L. C., Baluk, P., Srinivasan, R. S., Oliver, G. & McDonald, D. M. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am. J. Pathol. 180, 2561–2575 (2012).10.1016/j.ajpath.2012.02.019 ↗
36. Gerdes, J. et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67’. J. Immunol. 133, 1710–1715 (1984).10.4049/jimmunol.133.4.1710 ↗
37. Zuniga, K. et al. Keratin Promotes Differentiation of Keratinocytes Seeded on Collagen/Keratin Hydrogels. Bioengineering 9, 559 (2022).10.3390/bioengineering9100559 ↗
38. Alam, H., Sehgal, L., Kundu, S. T., Dalal, S. N. & Vaidya, M. M. Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. Mol. Biol. Cell 22, 4068–4078 (2011).10.1091/mbc.e10-08-0703 ↗
39. Moll, R., Divo, M. & Langbein, L. The human keratins: Biology and pathology. Histochem. Cell Biol. 129, 705–733 (2008).10.1007/s00418-008-0435-6 ↗
40. Nithya, S., Radhika, T. & Jeddy, N. Loricrin - An overview. J. Oral Maxillofac. Pathol. 19, 64–68 (2015).10.4103/0973-029X.157204 ↗
41. Bos, J. D. & Meinardi, M. M. H. M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9, 165–169 (2000).10.1034/j.1600-0625.2000.009003165.x ↗
42. Li, L. et al. Detection of saponins in extract of Panax notoginseng by liquid chromatography-electrospray ionisation-mass spectrometry. Anal. Chim. Acta 536, 21–28 (2005).10.1016/j.aca.2004.12.064 ↗
43. National Center for Biotechnology Information (2023). PubChem Compound Summary for CID 198016, Saponin. Retrieved March 3, 2023 from https://pubchem.ncbi.nlm.nih.gov/compound/Saponin.
44. Ahn, J. et al. Modeling of three-dimensional innervated epidermal like-layer in a microfluidic chip-based coculture system. Nat. Commun 14, 1488 (2023).10.1038/s41467-023-37187-4 ↗
45. Xu, Y. et al. Construction of a 980 nm laser-activated Pt(II) metallacycle nanosystem for efficient and safe photo-induced bacteria sterilization. Sci. China Chem. 66, 155–163 (2023).10.1007/s11426-022-1440-2 ↗
46. Xu, Y. et al. Long wavelength-emissive Ru(II) metallacycle-based photosensitizer assisting in vivo bacterial diagnosis and antibacterial treatment. https://doi.org/10.1073/pnas (2022).10.1073/pnas ↗